$1.98
arrow_drop_down10.20%Key Stats | |
---|---|
Open | $2.25 |
Prev. Close | $2.20 |
EPS | -1.46 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $596.86M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 2.15 | 2.30 |
52 Week Range | 1.16 | 10.65 |
Ratios | |
---|---|
EPS | -1.46 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop
Laboratory-Developed Tests (LDTs) World Market Forecast Report to 2028, with Coverage of the Effects of the FDA's New "Medical Devices: Laboratory Developed Tests" Rule, Passed in April 2024
Antibody Production Market to Surpass USD 36.49 Billion by 2032 Driven by Escalating Demand for Targeted Therapies and Technological Advancements | Research by SNS Insider
3 Conviction Bets Cathie Wood Is Doubling Down On
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now